Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Pacific-Link Regulatory Consulting LLC
Information provided by (Responsible Party):
Regimmune Inc.
ClinicalTrials.gov Identifier:
NCT01379209
First received: June 17, 2011
Last updated: October 26, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2015
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)